To disclose the potential role of LINC00665 in gemcitabine resistant CCA cells, we knocked down LINC00665 expression using two small hairpin RNA (shRNA) specifically targeting LINC00665 (sh-LINC0065-1 and sh-LINC00665-2). Here, LINC00665 is linked to cholangiocarcinoma.